Sublingual specific immunotherapy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Discover medicine

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 21034676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards evidence‐based medicine in specific grass pollen immunotherapy

  2010cited by this paper
• The safety of a novel sublingual rush induction phase for latex desensitization

  2010cited by this paper
• Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis.

  2010cited by this paper
• Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

  2010cited by this paper
• The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta‐analysis

  2009cited by this paper
• Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy

  2009cited by this paper
• Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

  2009cited by this paper
• Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity

  2009cited by this paper
• Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

  2009cited by this paper
• The immune privilege of the oral mucosa.

  2008cited by this paper
• Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study.

  2008cited by this paper
• Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

  2007cited by this paper
• Quantitative assessment of the compliance with once‐daily sublingual immunotherapy in children (EASY Project: Evaluation of A novel SLIT formulation during a Year)

  2007cited by this paper
• Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.

  2007cited by this paper
• Long-Lasting Effects of Sublingual Immunotherapy for House Dust Mites in Allergic Rhinitis with Bronchial Hyperreactivity: A Long-Term (13-Year) Retrospective Study in Real Life

  2006cited by this paper
• Once Daily Sublingual Immunotherapy without Updosing – A New Treatment Schedule

  2006cited by this paper
• Sublingual immunotherapy: a comprehensive review.

  2006cited by this paper
• Comparison of the Biological Activity of the Most Common Sublingual Allergen Solutions Made by Two European Manufacturers

  2006cited by this paper
• Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

  2006cited by this paper
• Sublingual immunotherapy in children modulates allergen‐induced in vitro expression of cytokine mRNA in PBMC

  2006cited by this paper
• Safety and Tolerability of Ultra-Rush Induction, Less than One Hour, of Sublingual Immunotherapy in Children

  2006cited by this paper
• Efficacy of sublingual immunotherapy in asthma: systematic review of randomized‐clinical trials using the Cochrane Collaboration method

  2006cited by this paper
• Five‐year follow‐up on the PAT study: specific immunotherapy and long‐term prevention of asthma in children

  2006cited by this paper
• Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

  2006cited by this paper
• Safety of a SQ‐standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo‐controlled trial

  2006cited by this paper
• Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

  2006cited by this paper
• A Pilot Study of Feasibility of Ultra-Rush (20–25 Minutes) Sublingual-Swallow Immunotherapy in 679 Patients (699 Sessions) with Allergic Rhinitis and/or Asthma

  2005cited by this paper
• Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study.

  2005cited by this paper
• Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years.

  2005cited by this paper
• Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

  2005cited by this paper
• Post‐marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

  2005cited by this paper
• Allergen-specific immunotherapy with recombinant grass pollen allergens.

  2005cited by this paper
• The safety of sublingual‐swallow immunotherapy: an analysis of published studies

  2005cited by this paper
• Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?

  2005cited by this paper
• Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis.

  2004cited by this paper
• Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

  2004cited by this paper
• Clinical efficacy of sublingual and subcutaneous birch pollen allergen‐specific immunotherapy: a randomized, placebo‐controlled, double‐blind, double‐dummy study

  2004cited by this paper
• Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.

  2004cited by this paper
• Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective study

  2003cited by this paper
• Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.

  2003cited by this paper
• Immunomodulation during sublingual therapy in allergic children

  2003cited by this paper
• TGF-beta regulates airway responses via T cells.

  2003cited by this paper
• Long‐term efficacy of preseasonal grass pollen immunotherapy in children

  2002cited by this paper
• Safety of sublingual immunotherapy with monomeric all_ergoid in adults: multicenter post‐marketing surveillance study

  2001cited by this paper
• Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial.

  1999cited by this paper
• Sublingual‐swallow immunotherapy (SLIT) with a standardized five‐grass‐pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

  1999cited by this paper
• Immunotherapy compliance--a shot in the dark?

  1995cited by this paper
• Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.

  1995cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• A prospective safety‐monitoring study of immunotherapy with biologically standardized extracts

  1993cited by this paper
• Changes in specific B cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes.

  1984cited by this paper

• Evolution Of Immunotherapy Against Pollen Allergy.

  2023cites this paper
• Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis

  2015cites this paper
• Noninvasive immunization strategies to target dendritic cells and protect against experimental otitis media due to nontypeable Haemophilus influenzae

  2011cites this paper
• Sublingual immunotherapy: administration, dosages, use.

  2009cites this paper